Patients living with cystic fibrosis are given a better outlook with the introduction of a drug called Trikafta. Over the years the median age of those with cystic fibrosis has increased and trikafta is seen as the next step in help for those living with cystic fibrosis. The drug, highly effective CFTR modulator therapy, has seen great results including regaining lung function, coughing less, and even not requiring a lung transplant. This could not be done without the help of the Cystic Fibrosis Foundation. More information online at www.slucare.edu

This is a clip from The Science of Healing: Cystic Fibrosis which aired Monday, July 26, 2021, on KMOV-TV 4 in St. Louis.

To schedule an appointment with a SLUCare physician, please call (314) 977-4440.

SLUCare Physician Group is a patient-centered network of more than 500 health care providers on staff at Saint Louis University School of Medicine. As part of an academic medical practice, SLUCare physicians are experts in their respective fields, providing specialty care for even the most complex medical conditions. SLUCare physicians practice in 47 different hospitals and clinics throughout the St. Louis region, making high-quality, advanced care convenient for you and your family.